NEW YORK — Nourish, a fast-growing provider of virtual nutrition counseling, has secured $70 million in Series B funding as it continues to expand its AI-powered platform for tackling chronic diseases through personalized nutrition care. The latest round, led by J.P. Morgan Private Capital’s Growth Equity Partners with participation from Thrive Capital, Index Ventures, Y Combinator, Atomico, and others, brings the company’s total funding to $115 million.
The funding will support Nourish’s efforts to scale its product development, grow its network of Registered Dietitians (RDs), and deepen collaborations with healthcare partners nationwide. The company plans to expand its team across all areas as it accelerates its mission to make nutrition a first-line treatment in chronic disease management.
Founded just over three years ago by three friends who experienced the transformative power of nutrition firsthand, Nourish connects patients, dietitians, and insurance payers through a fully integrated virtual care platform. This model makes it easier for patients to access high-quality, insurance-covered dietary care for conditions like diabetes, obesity, and heart disease. Today, Nourish serves hundreds of thousands of patients across all 50 states and operates the largest network of dietitians in the country, with over 3,000 W-2 RDs. The company partners with major commercial insurers as well as Medicare and Medicaid plans, covering hundreds of millions of lives, with 94% of patients paying nothing out of pocket.
“We built Nourish to make healthcare radically better for millions of Americans — it’s the care we wanted for ourselves,” said Aidan Dewar, co-founder and CEO of Nourish. “Our goal is to make lifestyle change and nutrition the foundation of chronic disease treatment, not an afterthought. By combining advanced AI with the best dietitian team in the country, we’re delivering care that works, is accessible, and feels more human.”
Nourish’s approach is rooted in the belief that nutrition-related chronic diseases, such as obesity, diabetes, and heart disease, represent the most pressing and overlooked healthcare crisis in the U.S. Nearly 60% of Americans live with at least one chronic condition, and 40% with two or more. While working with a dietitian is one of the most effective interventions, less than 1% of eligible individuals utilize their insurance-covered benefits due to lack of awareness and access.
Nourish’s virtual care model is already demonstrating significant clinical results. Data shows patients using GLP-1 medications like Ozempic experienced 33% more weight loss when working alongside a Nourish dietitian, with better medication adherence and fewer side effects. Other clinical markers, such as A1C and LDL cholesterol, have also shown measurable improvement among patients.
“Our healthcare system is facing an inflection point as chronic disease rates and costs soar,” said Sam Perkins, co-founder and President of Nourish. “Payers are looking for scalable solutions that deliver real results. Nourish addresses the root cause of chronic disease, offering a powerful lever to improve patient outcomes while controlling healthcare costs.”
The company’s platform offers AI-driven tools for both patients and dietitians. Patients benefit from features such as AI meal tracking, wearable and lab integrations, and personalized recipes. Meanwhile, Nourish equips its dietitians with an AI-powered copilot that automates note-taking, highlights clinical insights, and reduces administrative burdens, allowing them to focus more on patient care.
“Nourish is addressing one of the nation’s most urgent health challenges with an outcomes-driven, AI-native approach,” said Paris Heymann, Co-Managing Partner at J.P. Morgan Growth Equity Partners. “We’re proud to support Nourish as they continue to define this category, blending mission and measurable impact.”
With this latest funding, Nourish plans to deepen its reach and reinforce its position at the intersection of AI, nutrition, and chronic disease management, working toward a healthcare system where food and lifestyle changes are central to treatment.
